May be administered by registered competent doctor or nurse/midwife
Clindamycin 600mg per 4ml ampoule (Fresenius Kabi)
Clindamycin 300mg per 2ml ampoule (Fresenius Kabi)
Dalacin C Phosphate 300mg per 2ml ampoule
Dalacin C Phosphate 600mg per 4ml ampoule
Already in solution
Draw up using a 5 micron filter needle
Dilute further prior to administration
Sodium chloride 0.9% or Glucose 5%
Intermittent intravenous infusion
Dose | Diluent | Duration of infusion |
---|---|---|
300mg | 50mL* | over at least 10 minutes |
600mg | 50mL* | over at least 20 minutes |
900mg | 50 to 100mL | over at least 30 minutes |
1200mg | 100mL | over at least 40 minutes |
i.e. maximum rate of administration 30mg per minute, maximum concentration 18mg per mL |
||
* 50mL volumes: the residual volume in the infusion line must be flushed through at the same rate to avoid significant underdosing |
||
Fluid restricted: maximum concentration 18mg/mL. Each 300mg in minimum 17mL infusion fluid |
Usual dose (ref 1) -
Life-threatening infections e.g.Necrotising fasciitis/gas gangrene (Group A Streptococcal infection) Discuss with Microbiology or Infectious Diseases (ref 1)
Pelvic inflammatory disease (penicillin allergy) (ref 1)
Pyelonephritis in pregnancy (penicillin allergy)(ref 1)
Peri-tonsillar abscess (where penicillin allergy: immediate or severe delayed reaction) (ref 1)
SPC for Dalacin C October 2024
SPC for Fresenius Kabi product October 2021
1. Antimicrobial Prescribing Guidelines for GUH
Antibiotic